D-0897-2017 Class III Terminated
FDA drug recall D-0897-2017 was initiated by Hetero USA Inc on Apr 27, 2017 and is designated Class III. Reason for recall: Presence of Foreign Substance: human hair melded into tablet. The recall status is terminated (terminated Dec 13, 2017). Affected quantity: 13,692 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 14, 2017
- Initiation Date
- Apr 27, 2017
- Termination Date
- Dec 13, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 13,692 bottles
Product description
Acyclovir Tablets, USP, 800 mg, 100-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, by Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-778-01
Reason for recall
Presence of Foreign Substance: human hair melded into tablet.
Distribution pattern
Nationwide
Code information
Lot # ACY16075 Exp. 09/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0897-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026